Furthermore, we aimed to investigate the association of the KRAS variant with breast tumor characteristics among Slovenian postmenopausal sporadic breast cancer cases stratified by hormone replacement therapy (HRT) use. This evidence concerns the gene KRAS and breast carcinoma.